Omeros Corporation (OMER) Plunges 11.18% on March 04

[ad_1]

Omeros Corporation (OMER) had a rough trading day for Thursday March 04 as
shares
tumbled 11.18%, or a loss of $-2.23 per share, to close at $17.72. After opening the day at $19.79, shares of Omeros Corporation traded as high as $20.29 and as
low as $17.50. Volume was 1.31 million shares over 12,089 trades, against an average daily volume of n/a shares and a total float of 61.93 million.

As a result of the decline, Omeros Corporation now has a market cap of $1.1 billion. In the last
year, shares of Omeros Corporation have traded between a range of $25.46 and $8.50, and its 50-day SMA is currently $n/a and 200-day SMA is $n/a.

For a complete fundamental analysis of Omeros Corporation, check out Equities.com’s Stock Valuation Analysis report for
OMER
.

Still paying commissions on stock trades? Equities.com now offers $7.99/month unlimited trading and flat-fee options trading for $89.99/month! Get started today by https://www.equities.com/trading-start

Omeros Corp is a United States-based biopharmaceutical company. Its goal is to research, develop, and commercialize small-molecule and protein therapeutics targeting inflammation, coagulopathies, and disorders of the central nervous system. The company owns Omidria (phenylephrine and ketorolac injection), approved by the U.S. Food and Drug Administration and launched in the U.S. for use during cataract surgery and intraocular lens replacement. Its product pipeline is focused on complement-associated thrombotic microangiopathies; complement-mediated glomerulonephropathies; Huntington’s disease and cognitive impairment; and addictive and compulsive disorders.

Omeros Corporation is based out of Seattle, WA and has some 258 employees. Its CEO is Gregory A. Demopulos.

Omeros Corporation is a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It’s maintained by Russell Investments, an
industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell’s indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an
objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It’s a simple approach that gives
a broad, unbiased look at the small-cap market as a whole.


To get more information on Omeros Corporation and to follow the company’s latest updates, you can visit the company’s profile page here:
OMER’s Profile
. For more news on the financial markets and emerging growth companies, be sure to visit Equities.com’s
Newsdesk
. Also, don’t forget to sign-up for our daily
email newsletter
to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE:
The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer



[ad_2]

Source link

Elena Johaness

Leave a Reply

Your email address will not be published. Required fields are marked *